The assessment of Insulin-like Growth Factor 1 (IGF-1) levels is a common practice in endocrinology, often used to evaluate growth disorders, pituitary function, and nutritional status. A Z-score, in this context, represents the number of standard deviations a patient’s IGF-1 level deviates from the average IGF-1 level for individuals of the same age and sex. For example, an IGF-1 Z-score of +2 indicates that the patient’s IGF-1 level is two standard deviations above the mean for their demographic group, while a Z-score of -1 signifies one standard deviation below the mean.
Calculating a standardized score offers several advantages over using raw IGF-1 values. Raw IGF-1 concentrations naturally vary with age, with higher levels typically observed during puberty and lower levels in older adults. Standardizing the value against age and sex norms helps clinicians better interpret the IGF-1 measurement. The process mitigates the confounding effect of normal physiological variation, allowing for more accurate identification of true abnormalities. It is a powerful tool in the diagnosis of conditions such as growth hormone deficiency or excess, as well as in monitoring treatment efficacy.
